Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

HIV Clinical Trials

111 recruiting trials for HIV. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
111
Total Trials
111
Recruiting Now
6
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT07112001

A Behavioral mHealth Intervention for People With HIV With Anxiety and Depression

This study will adapt and assess the preliminary effectiveness of a community health worker-delivered mental health counselling intervention delivered remotely to reduce anxiety...

Sponsor: University of FloridaEnrolling: 601 location
RECRUITINGNCT05929911

Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD

People living with HIV (PLWH) have a higher rate of post-traumatic stress disorder (PTSD) diagnosis than the general population. Comorbid PTSD is also associated with negative...

Sponsor: Montefiore Medical CenterEnrolling: 201 location
RECRUITINGNCT06370481

HIV, Equity, and Addiction Training (HEAT) Program

This project is a pilot study to determine the feasibility and acceptability of a telemedicine intervention for substance use disorder service delivery in diverse people living...

Sponsor: University of Alabama at BirminghamEnrolling: 301 location
RECRUITINGNCT05934305

Mitigating the Impact of Stigma and Shame Among People Living With HIV and Substance Use Disorders

People living with HIV and substance use disorders (SUDs) are less likely to be virally suppressed, which can lead to HIV transmission and negative health outcomes. This hybrid...

Sponsor: Boston UniversityEnrolling: 2562 locations
RECRUITINGPhase 4NCT05669534

Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEP

The investigators will conduct an optimization trial among N=256 PWID newly started on medication for opioid use disorder and Pre-Exposure Prophylaxis (PrEP) to assess the...

Sponsor: University of ConnecticutEnrolling: 2561 location
RECRUITINGEarly Phase 1NCT06113003

The Gut, Liver And Metabolome in Human Immunodeficiency Virus and Non Alcoholic Fatty Liver Disease

Persons with human immunodeficiency virus (HIV) have higher risk of developing fatty liver disease (NAFLD) than HIV-negative persons but the reasons for this discrepancy are not...

Sponsor: Vanderbilt University Medical CenterEnrolling: 631 location
RECRUITINGNCT06940375

Incidence of Liver Disease-Related Outcomes in People With HIV

Antiretroviral therapy can effectively control the replication of HIV, prolong the lifespan of patients infected with HIV, and improve their quality of life.At the same time,...

Sponsor: Shanghai Public Health Clinical CenterEnrolling: 3202 locations
RECRUITINGNCT05917210

Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda

This cluster-randomized trial in Uganda will evaluate the effectiveness and implementation of a novel, peer-led TB education and counseling strategy to improve outcomes among...

Sponsor: Yale UniversityEnrolling: 19201 location
RECRUITINGNCT07312266

Questioning the Epidemiology of Asymptomatic TB

Tuberculosis (TB) remains one of the world's leading causes of morbidity and mortality. Current TB control strategies focus largely on the binary paradigm of TB, which tackle Mtb...

Sponsor: Barcelona Institute for Global HealthEnrolling: 67701 location
RECRUITINGNCT07117370

Assessing the Feasibility of Coach Mpilo for Men With TB and HIV

Men are less likely to report TB-related symptoms, get diagnosed, smear convert, or complete treatment, suggesting that outcomes along the TB cascade are worse for men. Despite...

Sponsor: Arizona State UniversityEnrolling: 2401 location
RECRUITINGNCT04230395

Alcohol Reduction Among People With TB and HIV in India

The highest incidence of tuberculosis disease (TB) in the world is in India, accounting for 27% of all new cases globally, with approximately 86,000 among persons with HIV (PWH)....

Sponsor: Johns Hopkins UniversityEnrolling: 4502 locations
RECRUITINGPhase 3NCT06497465

Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment

This will be a Phase IIIb Clinical Trial, an international multicenter, randomized, three-arm, non-comparative trial of efficacy, safety, and tolerability of the dual therapy...

Sponsor: Johns Hopkins UniversityEnrolling: 1506 locations
RECRUITINGPhase 2NCT04521803

High vs. Standard Dose Rifampicin for Effusive Tuberculous Pericarditis

The investigators hypothesise that high dose RIF (RIF35) will increase pericardial fluid RIF exposure and so enhance mycobacterial clearance, compared to standard of care dosing...

Sponsor: University of Cape TownEnrolling: 602 locations
RECRUITINGPhase 3NCT07071623

A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)

Researchers are looking for new medicines to prevent HIV-1 (Human Immunodeficiency Virus Type 1) infection. The goals of this study are to learn: * If taking MK-8527 once a...

Sponsor: Merck Sharp & Dohme LLCEnrolling: 458020 locations
RECRUITINGPhase 2NCT05947890

Evaluating the Safety and Immunogenicity of MTBVAC

The purpose of this study is to evaluate the safety and immunogenicity of MTBVAC in adolescents and adults living with and without HIV in South Africa

Sponsor: HIV Vaccine Trials NetworkEnrolling: 27616 locations
RECRUITINGPhase 4NCT07031063

Safety, Tolerability and Effectiveness of DTG/3TC vs BIC/TAF/FTC in PWH Without Antiretroviral Experience

Background: The primary goal of antiretroviral therapy is to prevent HIV-associated morbidity and mortality. The effectiveness of first-line regimens is supported by a large...

Sponsor: Instituto Mexicano del Seguro SocialEnrolling: 1241 location
RECRUITINGPhase 2NCT06839989

An Immunogenicity and Safety Trial of MVA-BN in Adults Living With HIV for the Prevention of Mpox Infection, in...

This is an open-label, phase 2, immunogenicity and safety trial of the MVA-BN vaccine for the prevention of mpox in adults living with HIV with different level of CD4 counts in...

Sponsor: Institute of Tropical Medicine, BelgiumEnrolling: 6001 location
RECRUITINGNCT05404750

Harm Reduction in HIV Primary Care for PLWH Who Use Drugs

People living with HIV (PLWH) who use drugs experience significant health disparities including lower rates of retention in HIV care and higher rates of unsuppressed viral load,...

Sponsor: University of PittsburghEnrolling: 7683 locations
RECRUITINGNCT07231640

PrOTECT AL: PrEP Optimization Through Enhanced Continuum Tracking

The purpose of this study is to enhance and evaluate the implementation of a PrEP Care Continuum data dashboard across seven distinct clinical sites in Alabama. By leveraging...

Sponsor: University of Alabama at BirminghamEnrolling: 561 location
RECRUITINGNCT07064785

Video-Intervention to Inspire Treatment Adherence for Life for Adolescents

This a two-arm randomized controlled trial whose objective is to explore the impact of VITAL Start for Adolescents (VS4A), a video-based antiretroviral treatment (ART) adherence...

Sponsor: Baylor College of MedicineEnrolling: 180020 locations
RECRUITINGNCT04577313

HIV Treatment Adherence Dose Determination Trial

The proposed research will conduct the first dose-determination trial to find the optimal number of behavioral counseling sessions (dose) needed to achieve and sustain optimal HIV...

Sponsor: University of ConnecticutEnrolling: 4002 locations
RECRUITINGPhase 1 / Phase 2NCT06719310

Phase Ib/IIa Clinical Study of ACC017 Tablets

ACC017 is an integrase inhibitor that will be evaluated for the treatment of HIV infection. This phase Ib/IIa, randomized, double-blind, parallel, dose ranging, placebo-controlled...

Sponsor: Jiangsu Aidea Pharmaceutical Group Co., Ltd.Enrolling: 361 location
RECRUITINGNCT06004011

AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW)

Adolescents and young adults living with HIV experience higher premature mortality from cancer than their uninfected peers. In Zambia, because of multilevel barriers,...

Sponsor: ImplenomicsEnrolling: 41001 location
RECRUITINGPhase 2NCT05719441

A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation...

A5388 is a phase II, two-arm, randomized, double-blind, placebo-controlled study that will enroll 48 antiretroviral therapy (ART)-naïve adults with acute HIV infection (AHI) in...

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)Enrolling: 4820 locations
RECRUITINGNCT05208541

Advancing Dignity, Health, and Optimism in Connection With Long Acting Injectables

ADHOC-LA is an observational study of people living with HIV who either are taking, or have taken, a long-acting injectable therapy to manage their HIV. Data from this study will...

Sponsor: Mazonson & Santas Inc.Enrolling: 2001 location
RECRUITINGNCT05624931

Reducing Psychological Barriers to PrEP Persistence Among Pregnant and Postpartum Women in Cape Town, South Africa

Pregnant women in South Africa (SA) are at high risk of HIV acquisition. Pre-exposure prophylaxis (PrEP) use during pregnancy is both safe and effective in preventing HIV....

Sponsor: Boston University Charles River CampusEnrolling: 1082 locations
RECRUITINGNCT06509113

A Pilot Study of an Online HIV Stigma Training for Nursing Students in Iran

In this study, the investigators will assess the feasibility, acceptability, and preliminary efficacy of online HIV stigma training in reducing stigmatizing attitudes and...

Sponsor: University of California, San FranciscoEnrolling: 701 location
RECRUITINGNCT06880224

Intensive Combination Approach to Rollback the HIV Epidemic in Nigerian Youth (iCARE) Plus Effectiveness/Implementation...

Two combination interventions (HIV Case Finding Intervention and HIV Treatment Intervention), each with mHealth and Peer Navigation components, will be evaluated in two 48-week...

Sponsor: Northwestern UniversityEnrolling: 5006 locations
RECRUITINGNCT03813862

Observational Pharmaco-Epidemiology Research & Analysis

Greater advances are needed in two separate but related areas in healthcare: 1) the Clinical Decision Support Systems that complement the EHR use in support of routine patient...

Sponsor: EpividianEnrolling: 20000001 location
RECRUITINGNCT05762705

A Mobile Gaming App to Improve Adherence to PrEP

In this study, the investigators will test the mobile game, Viral Combat, for efficacy and acceptability among diverse participants, ages 15-34 years, receiving PrEP care in...

Sponsor: Rhode Island HospitalEnrolling: 2003 locations
RECRUITINGNCT06103370

Syringe Service Based Telemedicine and Social Network Driven HIV Prevention Service Implementation

The goal of this clinical trial is to evaluate the effectiveness of a social network intervention to recruit people who inject drugs and their networks for HIV testing and linkage...

Sponsor: Johns Hopkins UniversityEnrolling: 3602 locations
RECRUITINGPhase 1NCT07042945

MK-4646 Multiple Dose Trial in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-4646-003)

This study will examine if at least one dose level of MK-4646 can lower HIV-1 viral load in a person's blood by a certain amount. The goals of this study are to learn about the...

Sponsor: Merck Sharp & Dohme LLCEnrolling: 282 locations
RECRUITINGPhase 2NCT06445166

Propranolol for the Treatment of Kaposi Sarcoma in Adults

Kaposi sarcoma (KS) lesions are initiated by endothelial cells infected with KS herpesvirus (KSHV), also known as human herpesvirus 8 (HHV-8). Lesion progression is driven by...

Sponsor: Washington University School of MedicineEnrolling: 251 location
RECRUITINGNCT07072481

Sustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing

Sustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing (S-ITEST), locally known as 4 Youth by Youth (4YBY) in Nigeria, builds on the investigator's previous...

Sponsor: Washington University School of MedicineEnrolling: 12161 location
RECRUITINGNCT07428330

Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV

This Clinical Trials Network for Human Immunodeficiency Virus (HIV)-Associated Cervical Cancer Screening and Treatment Optimization (CASCADE) -3001-A trial aims to assess how the...

Sponsor: UNC Lineberger Comprehensive Cancer CenterEnrolling: 16001 location
RECRUITINGNCT05090267

The Path Study: Cognitive and Inflammation Targeted Gut-brain Interventions in Alcohol; Probiotics, Alcohol,...

This project uses a hybrid trial design to evaluate two biomedical interventions targeting the gut-brain axis. One intervention is portable Transcutaneous Vagus Nerve Stimulator,...

Sponsor: University of FloridaEnrolling: 801 location
RECRUITINGNCT04378439

Appalachian Partnership to Reduce Disparities (Aim 2)

By combining two strategies (i.e., peer navigation and mHealth) into a complete, culturally compatible, bilingual intervention to increase the use of needed HIV, STI, and HCV...

Sponsor: Wake Forest University Health SciencesEnrolling: 1411 location
RECRUITINGNCT07186244

Prevention ICONA Dedicated Ensemble

Despite significant advances in HIV treatment, transmission remains a public health concern. In 2022, there were 1.3 million new HIV infections worldwide and 1,888 new diagnoses...

Sponsor: Fondazione ICONAEnrolling: 500020 locations
RECRUITINGNCT05342064

Closing -TB GAPs - for People Living With HIV: TB Guidance for Adaptable Patient-Centered Service

Tuberculosis (TB) is the world's leading infectious cause of mortality and responsible for 1/3 of deaths in people living with human immunodeficiency virus (PLHIV). Children and...

Sponsor: Baylor College of MedicineEnrolling: 65005 locations
RECRUITINGNCT04359186

SCOPE Analytic Treatment Interruption Protocol

The goal of this study is to understand the interaction between HIV and the host at the earliest stages when HIV medications are paused. Volunteers with HIV will interrupt...

Sponsor: University of California, San FranciscoEnrolling: 401 location
RECRUITINGNCT04738825

Promoting HIV Risk Reduction Among People Who Inject Drugs: A Stepped Care Approach Using Contingency Management With...

The proposed study will be a 24-week intervention with a 12-month follow-up period to evaluate the impact of contingency management with stepped care to pre-exposure prophylaxis...

Sponsor: Yale UniversityEnrolling: 5266 locations
RECRUITINGPhase 2NCT07030920

Reducing Systemic Inflammation in People on Antiretroviral Therapy

This randomized, open-label clinical trial will evaluate whether adding fostemsavir to current antiretroviral therapy can reduce the risk of cardiovascular disease in people with...

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)Enrolling: 1501 location
RECRUITINGNCT05404958

Systems Analysis and Improvement Approach to Improve Integration of HIV Prevention and Treatment Services

East and Southern Africa is home to 6.2% of the world's population but includes 54% of all people living with HIV (PLWH). In this region, three out of five PLWH are women, and...

Sponsor: University of WashingtonEnrolling: 401 location
RECRUITINGNCT06072443

AURORA Study-A Transformative Approach to Support PrEP Medication Persistence

This study is designed to test the hypothesis that, compared to oral PrEP, use of CAB-LA in underserved populations in a real-world setting supported by a digital health companion...

Sponsor: WV Health Right, Inc.Enrolling: 1051 location
RECRUITINGNCT06190613

Combination Intervention to Enhance Treatment Engagement and Viral Suppression Among Sexual and Gender Minority Youth...

The study will adapt and test a combination peer navigation and mHealth approach, Intensive Combination Approach to Rollback the Epidemic in Nigeria (iCARE Nigeria), to improve...

Sponsor: Northwestern UniversityEnrolling: 1001 location
RECRUITINGNCT05910268

Peru Decentralized HIV Care

The purpose of this study is to understand the processes by which HIV care is decentralized, an evidence-informed strategy to improve retention in HIV care, in Peru....

Sponsor: Yale UniversityEnrolling: 14502 locations
RECRUITINGPhase 3NCT05813964

Efficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in Thailand and France.

The purpose of this study is to evaluate the efficacy, acceptability, and safety of a simplified event-driven pre-exposure prophylaxis of HIV based on oral TAF/FTC in...

Sponsor: ANRS, Emerging Infectious DiseasesEnrolling: 5244 locations
RECRUITINGPhase 2NCT04319367

A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).

RIO is a placebo-controlled double-blinded two arm prospective phase II randomised controlled trial . This study will test the use of broadly neutralising antibodies (bNAbs) in...

Sponsor: Imperial College LondonEnrolling: 7212 locations
RECRUITINGNCT07425067

Upper Gastrointestinal Endoscopy in HIV-infected Individuals

The aim of this registry is to collect prospectively demographic characteristics and upper gastrointestinal endoscopy diagnoses over a long-term period, in people living with HIV,...

Sponsor: Centre Hospitalier Universitaire Saint PierreEnrolling: 25001 location
RECRUITINGNCT06141408

PrEP Intervention in Prince George's County, Maryland

The goal of the proposed research is to design a peer-based community intervention focused on addressing HIV stigma, and peer support to increase PrEP initiation in Prince...

Sponsor: George Mason UniversityEnrolling: 1201 location

Showing 50 of 111 trials.Search all HIV trials